Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner

Journal of Virology

Volumn 84, Issue 22, 2010, Pages 11761-11770

  Weng, Leiyun ^a   Hirata, Yuichi ^b   Arai, Masaaki ^c   Kohara, Michinori ^b   Wakita, Takaji ^d   Watashi, Koichi ^d,e   Shimotohno, Kunitada ^e,f   He, Ying ^a   Zhong, Jin ^a   Toyoda, Tetsuya ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b Tokyo Metropolitan Inst Technol   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MEMBRANE LIPID; RNA POLYMERASE; SPHINGOMYELIN; THERMOZYMOCIDIN;

ANTIVIRAL SUSCEPTIBILITY; ARTICLE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; REPLICON; RNA BINDING; VIRUS STRAIN; VIRUS TRANSCRIPTION;

ENZYME ACTIVATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RNA REPLICASE; SPECIES SPECIFICITY; SPHINGOMYELINS; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 78049524806     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00638-10     Document Type: Article

References (38)

1. Adams, N. J., R. W. Chamberlain, L. A. Taylor, F. Davidson, C. K. Lin, R. M. Elliott, and P. Simmonds. 1997. Complete coding sequence of hepatitis C virus genotype 6a. Biochem. Biophys. Res. Commun. 234:393-396.
2. Aizaki, H., K. J. Lee, V. M. Sung, H. Ishiko, and M. M. Lai. 2004. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324:450-461.
3. Aizaki, H., K. Morikawa, M. Fukasawa, H. Hara, Y. Inoue, H. Tani, K. Saito, M. Nishijima, K. Hanada, Y. Matsuura, M. M. Lai, T. Miyamura, T. Wakita, and T. Suzuki. 2008. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82:5715-5724.
4. Amemiya, F., S. Maekawa, Y. Itakura, A. Kanayama, A. Matsui, S. Takano, T. Yamaguchi, J. Itakura, T. Kitamura, T. Inoue, M. Sakamoto, K. Yamauchi, S. Okada, A. Yamashita, N. Sakamoto, M. Itoh, and N. Enomoto. 2008. Targeting lipid metabolism in the treatment of hepatitis C virus infection. J. Infect. Dis. 197:361-370.
5. Binder, M., D. Quinkert, O. Bochkarova, R. Klein, N. Kezmic, R. Bartenschlager, and V. Lohmann. 2007. Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J. Virol. 81:5270-5283. (Pubitemid 46744436)
6. Biswal, B. K., M. M. Cherney, M. Wang, L. Chan, C. G. Yannopoulos, D. Bilimoria, O. Nicolas, J. Bedard, and M. N. James. 2005. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by nonnucleoside inhibitors. J. Biol. Chem. 280:18202-18210.
7. Blight, K. J., J. A. McKeating, J. Marcotrigiano, and C. M. Rice. 2003. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 77:3181-3190.
8. Chamberlain, R. W., N. J. Adams, L. A. Taylor, P. Simmonds, and R. M. Elliott. 1997. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem. Biophys. Res. Commun. 236:44-49.
9. Chinnaswamy, S., I. Yarbrough, S. Palaninathan, C. T. Kumar, V. Vijayaraghavan, B. Demeler, S. M. Lemon, J. C. Sacchettini, and C. C. Kao. 2008. A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase. J. Biol. Chem. 283:20535-20546.
10. Chou, P. Y., and G. D. Fasman. 1974. Prediction of protein conformation. Biochemistry 13:222-245.
11. Fujimoto, T., H. Kogo, K. Ishiguro, K. Tauchi, and R. Nomura. 2001. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell Biol. 152:1079-1085.
12. Gottwein, J. M., T. K. Scheel, B. Callendret, Y. P. Li, H. B. Eccleston, R. E. Engle, S. Govindarajan, W. Satterfield, R. H. Purcell, C. M. Walker, and J. Bukh. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J. Virol. 84:5277-5293.
13. Hammache, D., G. Pieroni, N. Yahi, O. Delezay, N. Koch, H. Lafont, C. Tamalet, and J. Fantini. 1998. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273:7967-7971.
14. Hang, J. Q., Y. Yang, S. F. Harris, V. Leveque, H. J. Whittington, S. Rajyaguru, G. Ao-Ieong, M. F. McCown, A. Wong, A. M. Giannetti, S. Le Pogam, F. Talamas, N. Cammack, I. Najera, and K. Klumpp. 2009. Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus. J. Biol. Chem. 284:15517-15529.
15. Huang, H., F. Sun, D. M. Owen, W. Li, Y. Chen, M. Gale, Jr., and J. Ye. 2007. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 104:5848-5853.
16. Ishii, N., K. Watashi, T. Hishiki, K. Goto, D. Inoue, M. Hijikata, T. Wakita, N. Kato, and K. Shimotohno. 2006. Diverse effects of cyclosporine on hepatitis C virus strain replication. J. Virol. 80:4510-4520.
17. Kashiwagi, T., K. Hara, M. Kohara, K. Kohara, J. Iwahashi, N. Hamada, H. Yoshino, and T. Toyoda. 2002. Kinetic analysis of C-terminally truncated RNA-dependent RNA polymerase of hepatitis C virus. Biochem. Biophys. Res. Commun. 290:1188-1194.
18. Kato, T., T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami, and T. Wakita. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808-1817. (Pubitemid 37500445)
19. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, R. H. Purcell, et al. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675. (Pubitemid 20349249)
20. Lambot, M., S. Fretier, A. Op De Beeck, B. Quatannens, S. Lestavel, V. Clavey, and J. Dubuisson. 2002. Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J. Biol. Chem. 277:20625-20630.
21. Lemon, S., C. Walker, M. Alter, and M. Yi. 2007. Hepatitis C virus, p. 1253-1304. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
22. Mahfoud, R., N. Garmy, M. Maresca, N. Yahi, A. Puigserver, and J. Fantini. 2002. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 277:11292-11296.
23. Miyake, Y., Y. Kozutsumi, S. Nakamura, T. Fujita, and T. Kawasaki. 1995. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. 211: 396-403.
24. Miyanari, Y., K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
25. Murayama, A., T. Date, K. Morikawa, D. Akazawa, M. Miyamoto, M. Kaga, K. Ishii, T. Suzuki, T. Kato, M. Mizokami, and T. Wakita. 2007. The NS3 helicase and NS5B-to-3′X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J. Virol. 81:8030-8040. (Pubitemid 47101489)
26. Murayama, A., L. Weng, T. Date, D. Akazawa, X. Tian, T. Suzuki, T. Kato, Y. Tanaka, M. Mizokami, T. Wakita, and T. Toyoda. 2010. RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog. 6:e1000885.
27. Ostermeyer, A. G., J. M. Paci, Y. Zeng, D. M. Lublin, S. Munro, and D. A. Brown. 2001. Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J. Cell Biol. 152:1071-1078.
28. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, et al. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U. S. A. 87:6547-6549.
29. Sakamoto, H., K. Okamoto, M. Aoki, H. Kato, A. Katsume, A. Ohta, T. Tsukuda, N. Shimma, Y. Aoki, M. Arisawa, M. Kohara, and M. Sudoh. 2005. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 1:333-337.
30. Shi, S. T., K. J. Lee, H. Aizaki, S. B. Hwang, and M. M. Lai. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77:4160-4168.
31. Simister, P., M. Schmitt, M. Geitmann, O. Wicht, U. H. Danielson, R. Klein, S. Bressanelli, and V. Lohmann. 2009. Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J. Virol. 83:11926-11939.
32. Tsukiyama-Kohara, K., S. Tone, I. Maruyama, K. Inoue, A. Katsume, H. Nuriya, H. Ohmori, J. Ohkawa, K. Taira, Y. Hoshikawa, F. Shibasaki, M. Reth, Y. Minatogawa, and M. Kohara. 2004. Activation of the CKI-CDKRb-E2F pathway in full genome hepatitis C virus-expressing cells. J. Biol. Chem. 279:14531-14541.
33. Umehara, T., M. Sudoh, F. Yasui, C. Matsuda, Y. Hayashi, K. Chayama, and M. Kohara. 2006. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Biochem. Biophys. Res. Commun. 346:67-73.
34. Wasley, A., and M. J. Alter. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 20:1-16.
35. Watashi, K., N. Ishii, M. Hijikata, D. Inoue, T. Murata, Y. Miyanari, and K. Shimotohno. 2005. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19:111-122.
36. Weng, L., J. Du, J. Zhou, J. Ding, T. Wakita, M. Kohara, and T. Toyoda. 2009. Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain. Arch. Virol. 154:765-773.
37. Yasuda, S., H. Kitagawa, M. Ueno, H. Ishitani, M. Fukasawa, M. Nishijima, S. Kobayashi, and K. Hanada. 2001. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J. Biol. Chem. 276:43994-44002.
38. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.